Subscribe
2020-04-02
Pavel Kapysh / Shutterstock.com
16 December 2020AmericasSarah Morgan

Boston Scientific and Nevro conclude patent dispute

Medical device company  Nevro has agreed to drop a patent infringement suit which accused  Boston Scientific of infringing patents related to spinal cord stimulation (SCS) therapy.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Nevro escalates patent dispute with Boston Scientific
25 February 2021   Medical device maker Nevro has hit competitor Boston Scientific with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.
Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Americas
Nevro faces $20m damages in patent dispute with Boston Scientific
2 November 2021   Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
Nevro escalates patent dispute with Boston Scientific
25 February 2021   Medical device maker Nevro has hit competitor Boston Scientific with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.
Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Americas
Nevro faces $20m damages in patent dispute with Boston Scientific
2 November 2021   Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific.

More on this story

Americas
Nevro escalates patent dispute with Boston Scientific
25 February 2021   Medical device maker Nevro has hit competitor Boston Scientific with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.
Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Americas
Nevro faces $20m damages in patent dispute with Boston Scientific
2 November 2021   Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent